Unknown

Dataset Information

0

Identification of novel indole derivatives acting as inhibitors of the Keap1-Nrf2 interaction.

ABSTRACT: Nine indole derivatives (9a-i) were tested as potential inhibitors of the Keap1-Nrf2 interaction. This class of compounds increases the intracellular levels of the transcription factor Nrf2 and the consequent expression of enzymes encoded by genes containing the antioxidant response element (ARE). In the ARE-luciferase reporter assay only 9e-g revealed to be remarkably more active than t-butylhydroxyquinone (t-BHQ), with 9g standing out as the best performing compound. While 9e and 9f are weak acids, 9g is an ampholyte prevailing as a zwitterion in neutral aqueous solutions. The ability of 9e-g to significantly increase levels of Nrf2, NADPH:quinone oxidoreductase 1, and transketolase (TKT) gave further support to the hypothesis that these compounds act as inhibitors of the Keap1-Nrf2 interaction. Docking simulations allowed us to elucidate the nature of the putative interactions between 9g and Keap1.

SUBMITTER: Cosimelli B 

PROVIDER: S-EPMC6567006 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Identification of novel indole derivatives acting as inhibitors of the Keap1-Nrf2 interaction.

Cosimelli Barbara B   Greco Giovanni G   Laneri Sonia S   Novellino Ettore E   Sacchi Antonia A   Amendola Giorgio G   Cosconati Sandro S   Bortolozzi Roberta R   Viola Giampietro G  

Journal of enzyme inhibition and medicinal chemistry 20191201 1

Nine indole derivatives (<b>9a-i</b>) were tested as potential inhibitors of the Keap1-Nrf2 interaction. This class of compounds increases the intracellular levels of the transcription factor Nrf2 and the consequent expression of enzymes encoded by genes containing the antioxidant response element (ARE). In the ARE-luciferase reporter assay only <b>9e</b>-<b>g</b> revealed to be remarkably more active than <i>t</i>-butylhydroxyquinone (<i>t</i>-BHQ), with <b>9g</b> standing out as the best perfo  ...[more]

Similar Datasets

Unknown Development of an enzyme-linked immunosorbent assay for Keap1-Nrf2 interaction inhibitors identification.
| S-EPMC7231848 | biostudies-literature
Unknown Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors.
| S-EPMC5018864 | biostudies-other
Unknown Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning.
| S-EPMC8016952 | biostudies-literature
Unknown KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential.
| S-EPMC10087726 | biostudies-literature
Unknown Emerging Screening Approaches in the Development of Nrf2-Keap1 Protein-Protein Interaction Inhibitors.
| S-EPMC6770765 | biostudies-literature
Unknown Novel Prenylated Indole Alkaloids with Neuroprotection on SH-SY5Y Cells against Oxidative Stress Targeting Keap1-Nrf2.
| S-EPMC8952805 | biostudies-literature
Unknown Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids.
| S-EPMC6220877 | biostudies-literature
Unknown Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein-Protein Interaction Inhibitors with an Alternative Binding Mode.
| S-EPMC9150106 | biostudies-literature
Unknown Nrf2 activation through the inhibition of Keap1-Nrf2 protein-protein interaction.
| S-EPMC7207041 | biostudies-literature
Unknown Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 Interaction.
| S-EPMC7236277 | biostudies-literature